Njengakwamanye amazwe amaninzi, i-US Food and Drug Administration (FDA) isebenzela ukwenza uvavanyo lwesifo se-coronavirus lusasazeke kangangoko kunokwenzeka. Enye yezi mveliso inokuba linyathelo elikhulu ukuya phambili kubuchwephesha bokulwa esi sifo.
Inkampani ye-Abbott kusetyenziso olungxamisekileyo lwe-ID yayo enobungakanani betoaster NGOKU mini-labhu. Isixhobo siyakwazi ukubonelela ngeziphumo kwimizuzu nje emi-5 xa sivavanya umntu i-Covid-19, kwaye sibonelela ngoxilongo oluchanekileyo ngemizuzu eli-13. Ikwangomnye weemvavanyo ezimbalwa zohlobo lwayo ezinokuthi zisetyenziswe ngaphandle kwesibhedlele, njengasekliniki.
Undoqo kukusebenzisa uvavanyo lwemolekyuli, olujonga iqhekeza elincinci, elinophawu lwe-RNA evela kwintsholongwane ye-SARS-CoV-2 kwi-biomaterial ethathwe kwisigulana, endaweni ye-antibodies efana nolunye uvavanyo. Ezinye iindlela zinokuthatha iiyure okanye iintsuku.
U-Abbott sele enyusa imveliso kwaye ulindele ukuthumela iimvavanyo ezingama-50 ngosuku ukuya e-US ukuqala kwiveki ezayo. Nangona kunjalo, enye yeenzuzo eziphambili inokuba yinethiwekhi ekhoyo yenkampani. Iqonga le-ID NGOKU sele linobukho bukhulu balo naluphi na uvavanyo lwemolekyuli e-United States kwaye ifumaneka ngokubanzi kwiiofisi zoogqirha kunye namagumbi kaxakeka. Ukuba konke kuhambe kakuhle, iUnited States kungekudala iza kukwazi ukufumana ukuqonda ngokuchanekileyo ngakumbi malunga nobhubhane kwaye ke ngoko iphendule ngcono kwinto eyenzekayo, ibonelele abo bosulelwe ngokhathalelo oluyimfuneko ngokukhawuleza okukhulu.
umthombo: 3dnews.ru